US 5789538A
· Rebar et al.
· 1998
[cited by applicant]
US 5925523A
· Dove et al.
· 1999
[cited by applicant]
US 5928638A
· Uchida et al.
· 1999
[cited by applicant]
US 6007988A
· Choo et al.
· 1999
[cited by applicant]
US 6013453A
· Choo et al.
· 2000
[cited by applicant]
US 6140081A
· Barbas
· 2000
[cited by applicant]
US 6200759B1
· Dove et al.
· 2001
[cited by applicant]
US 6309634B1
· Bankiewicz et al.
· 2001
[cited by applicant]
US 6453242B1
· Eisenberg et al.
· 2002
[cited by applicant]
US 6503717B2
· Case et al.
· 2003
[cited by applicant]
US 6534261B1
· Cox, III et al.
· 2003
[cited by applicant]
US 6599692B1
· Case et al.
· 2003
[cited by applicant]
US 6607882B1
· Cox, III et al.
· 2003
[cited by applicant]
US 6689558B2
· Case
· 2004
[cited by applicant]
US 6746838B1
· Choo et al.
· 2004
[cited by applicant]
US 6824978B1
· Cox, III et al.
· 2004
[cited by applicant]
US 6866997B1
· Choo et al.
· 2005
[cited by applicant]
US 6933113B2
· Case et al.
· 2005
[cited by applicant]
US 6953575B2
· Bankiewicz et al.
· 2005
[cited by applicant]
US 6979539B2
· Cox, III et al.
· 2005
[cited by applicant]
US 7013219B2
· Case et al.
· 2006
[cited by applicant]
US 7067317B2
· Rebar et al.
· 2006
[cited by applicant]
US 7074596B2
· Darzynkiewicz et al.
· 2006
[cited by applicant]
US 7163824B2
· Cox, III et al.
· 2007
[cited by applicant]
US 7182944B2
· Bankiewicz
· 2007
[cited by applicant]
US 7241573B2
· Choo et al.
· 2007
[cited by applicant]
US 7241574B2
· Choo et al.
· 2007
[cited by applicant]
US 7262054B2
· Jamieson et al.
· 2007
[cited by applicant]
US 7837668B2
· Gasmi et al.
· 2010
[cited by applicant]
US 7888121B2
· Urnov et al.
· 2011
[cited by applicant]
US 7914796B2
· Miller et al.
· 2011
[cited by applicant]
US 7951925B2
· Ando et al.
· 2011
[cited by applicant]
US 7972854B2
· Miller et al.
· 2011
[cited by applicant]
US 8034598B2
· Miller
· 2011
[cited by applicant]
US 8092429B2
· Gasmi et al.
· 2012
[cited by applicant]
US 8110379B2
· DeKelver et al.
· 2012
[cited by applicant]
US 8153773B2
· Jemielity et al.
· 2012
[cited by applicant]
US 8309355B2
· Bankiewicz et al.
· 2012
[cited by applicant]
US 8337458B2
· Bankiewicz et al.
· 2012
[cited by applicant]
US 8409861B2
· Guschin et al.
· 2013
[cited by applicant]
US 8586526B2
· Gregory et al.
· 2013
[cited by applicant]
US 8597912B2
· Collingwood et al.
· 2013
[cited by applicant]
US 8623618B2
· Doyon et al.
· 2014
[cited by applicant]
US 8703489B2
· Wang
· 2014
[cited by applicant]
US 8841260B2
· Miller et al.
· 2014
[cited by applicant]
US 8945868B2
· Collingwood et al.
· 2015
[cited by applicant]
US 8956828B2
· Bonini et al.
· 2015
[cited by applicant]
US 9005973B2
· Cost et al.
· 2015
[cited by applicant]
US 9045763B2
· DeKelver et al.
· 2015
[cited by applicant]
US 9050299B2
· Bankiewicz
· 2015
[cited by applicant]
US 9089667B2
· Bankiewicz
· 2015
[cited by applicant]
US 20030232410A1
· Liljedahl et al.
· 2003
[cited by applicant]
US 20040034888A1
· Liu et al.
· 2004
[cited by applicant]
US 20060063231A1
· Li et al.
· 2006
[cited by applicant]
US 20060239966A1
· Tornoe et al.
· 2006
[cited by applicant]
US 20070283460A9
· Liu et al.
· 2007
[cited by applicant]
US 20090068164A1
· Segal et al.
· 2009
[cited by applicant]
US 20120195936A1
· Rudolph et al.
· 2012
[cited by applicant]
EP 2441774A1
· 2012
[cited by applicant]
WO WO9519431A1
· 1995
[cited by applicant]
WO WO9606166A1
· 1996
[cited by applicant]
WO WO9853057A1
· 1998
[cited by applicant]
WO WO9853058A1
· 1998
[cited by applicant]
WO WO9853059A1
· 1998
[cited by applicant]
WO WO9853060A1
· 1998
[cited by applicant]
WO WO9854311A1
· 1998
[cited by applicant]
WO WO0027878A1
· 2000
[cited by applicant]
WO WO0160970A2
· 2001
[cited by applicant]
WO WO0188197A2
· 2001
[cited by applicant]
WO WO0216536A1
· 2002
[cited by applicant]
WO WO02099084A2
· 2002
[cited by applicant]
WO WO03016496A2
· 2003
[cited by applicant]
WO WO10079430A1
· 2010
[cited by applicant]
WO WO2011016840A1
· 2011
[cited by applicant]
WO WO2011016840A2
· 2011
[cited by applicant]
WO WO2012049332A1
· 2012
[cited by applicant]
WO WO2013130824A1
· 2013
[cited by applicant]
WO WO2016183298A2
· 2016
[cited by applicant]
Garriga-Canut et al. (2012) PNAS, Early Edition, www.pnas.org/cgi/doi/10.1073/pnas.1206506109, pp. 1-10.
[cited by examiner]
An, et al., “Genetic Correction of Huntington's Disease Phenotypes in Induced Pluripotent Stem Cells,”
[cited by applicant]
Berardelli, et al. “Pathophysiology of Chorea and Bradykinesia in Huntington's Disease,”
[cited by applicant]
Beurdeley, et al., “Compact Designer Talens for Efficient Genome Engineering,”
[cited by applicant]
Boch, et al., “Breaking the Code of Dna Binding Specificity of Tal-Type III Effectors,”
[cited by applicant]
Boissel, et al., “Megatals: A Rare-Cleaving Nuclease Architecture for Therapeutic Genome Engineering,”
[cited by applicant]
Bonas, et al., “Genetic and Structural Characterization of the Avirulence Gene AVRBS3 From Xanthomonas Campestris PV. Vesicatoria,”
[cited by applicant]
Brouns, et al., “Small CRISPR RNAS Guide Antiviral Defense in Prokaryotes,”
[cited by applicant]
Chae, et al., “Quantitative Proteomic Analysis of Induced Pluripotent Stem Cells Derived From a Human Huntington's Disease Patient,”
[cited by applicant]
Ciesielska, et al., “Anterograde Axonal Transport of AAV2-GDNF in Rat Basal Ganglia,”
[cited by applicant]
Ciesielska, et al., “Cerebral Infusion of AAV9 Vector-Encoding Non-Self Proteins Can Elicit Cell-Mediated Immune Responses,”
[cited by applicant]
Cong, et al., “Multiplex Genome Engineering Using CRISPR/CAS Systems,”
[cited by applicant]
Davies, et al., “Polyalanine and Polyserine Frameshift Products in Huntington's Disease,”
[cited by applicant]
Di Prospero, et al., “Therapeutics Development for Triplet Repeat Expansion Diseases,”
[cited by applicant]
Esvelt, et al., “Orthogonal CAS9 Proteins for RNA-Guided Gene Regulation and Editing,”
[cited by applicant]
Fiandaca, et al., “Image-Guided Convection-Enhanced Delivery Platform in the Treatment of Neurological Diseases,”
[cited by applicant]
Fiandaca, et al. “Real-Time Mr Imaging of Adeno-Associated Viral Vector Delivery To the Primate Brain,”
[cited by applicant]
Fonfara, et al., “Phylogeny of CAS9 Determines Functional Exchangeability of Dual-RNA and CAS9 Among Orthologous Type II CRISPR-CAS Systems,”
[cited by applicant]
Forsayeth, et al., “Transduction of Antigen-Presenting Cells in the Brain By AAV9 Warrants Caution in Preclinical Studies,”
[cited by applicant]
Foust, et al. “Intravascular AAV9 Preferentially Targets Neonatal-Neurons and Adult-Astrocytes in Cns,”
[cited by applicant]
Garriga-Canut, et al. “Synthetic Zinc Finger Repressors Reduce Mutant Huntingtin Expression in the Brain of R6/2 Mice,”
[cited by applicant]
Godde, et al., “The Repetitive DNA Elements Called CRISPRS and Their Associated Genes: Evidence of Horizontal Transfer Among Prokaryotes,”
[cited by applicant]
Graham, et al., “Cleavage at the CASPASE-6 Site is Required for Neuronal Dysfunction and Degeneration Due to Mutant Huntingtin,”
[cited by applicant]
Gray, et al. “Preclinical Differences of Intravascular AAV9 Delivery To Neurons and Glia: a Comparative Study of Adult Mice and Nonhuman Primates,”
[cited by applicant]
Hadaczek, et al. “The Perivascular Pump Driven ny Arterial Pulsation is a Powerful Mechanism for the Distribution of Therapeutic Molecules Within the Brain,”
[cited by applicant]
Haft, et al., “A Guild Of 45 CRISPR-Associated (CAS) Protein Families and Multiple CRISPR/CAS Subtypes Exist in Prokaryotic Genomes,”
[cited by applicant]
Hale, et al., “Prokaryotic Silencing (PSI)RNAS in Pyrococcus Furiosus,”
[cited by applicant]
Heuer, et al., “Repeat Domain Diversity of AVRBS3-Like Genes in Ralstonia Solanacearum Strains and Association With Host Preferences in the Field,”
[cited by applicant]
Hinderer et al., “Widespread Gene Transfer in the Central Nervous System of Cynomolgus Macaques Following Delivery of AAV9 Into the Cisterna Magna,”
[cited by applicant]
Hsu, et al., “DNA Targeting Specificity of Rna-Guided CAS9 Nucleases,”
[cited by applicant]
Huntington Study Group, “Unified Huntington's Disease Rating Scale (UHDRS) Reliability and Consistency,”
[cited by applicant]
Hwang, et al., “Efficient in Vivo Genome Editing Using RNA-Guided Nucleases,”
[cited by applicant]
Jansen, et al., “Identification of Genes That Are Associated With DNA Repeats in Prokaryotes,”
[cited by applicant]
Jinek, et al., “A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity,”
[cited by applicant]
Kay, et al., “A Bacterial Effector Acts as a Plant Transcription Factor and Induces a Cell Size Regulator,”
[cited by applicant]
Kells, et al., “AAV-Mediated Gene Delivery of BDNF or GDNF is Neuroprotective in a Model of Huntington Disease,”
[cited by applicant]
Kells, et al., “Efficient Gene Therapy-Based Method for the Delivery of Therapeutics To Primate Cortex,”
[cited by applicant]
Kells, et al., “Glial-Derived Neurotrophic Factor Gene Transfer for Parkinson's Disease: Anterograde Distribution of AAV2 Vectors in the Primate Brain,”
[cited by applicant]
Kormann, et al., Expression of Therapeutic Proteins After Delivry of Chemically Modified mRNA In Mice,
[cited by applicant]
Krauze, et al., “Reflux-Free Cannula for Convection-Enhanced High-Speed Delivery of Therapeutic Agents,”
[cited by applicant]
Lillestol, et al., “A Putative Viral Defence Mechanism in Archaeal Cells,”
[cited by applicant]
Makarova, et al., “A DNA Repair System Specific for Thermophilic Archaea and Bacteria Predicted by Genomic Context Analysis,”
[cited by applicant]
Makarova, et al., “A Putative RNA-Interference-Based Immune System in Prokaryotes: Computational Analysis of the Predicted Enzymatic Machinery, Functional Analogies With Eukaryotic RNAI, and Hypothetical Mechanisms of A…
[cited by applicant]
Mattis, et al., “Induced Pluripotent Stem Cells From Patients With Huntington's Disease Show Cag Repeat Expansion Associated Phenotypes,”
[cited by applicant]
Moscou, et al., “A Simple Cipher Governs DNA Recognition by TAL Effectors,”
[cited by applicant]
Niccolini, et al., “Altered PDE10A Expression Detectable Early Before Symptomatic Onset in Huntington's Disease,”
[cited by applicant]
Perez-Pinera, et al., “RNA-Guided Gene Activation By CRISPR-CAS9-Based Transcription Factors,”
[cited by applicant]
Piatek, et al., “RNA-Guided Transcriptional Regulation in Planta via Synthetic DCAS9-Based Transcription Factors,”
[cited by applicant]
Richardson, et al., “Interventional MRI-Guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease,”
[cited by applicant]
Richardson, et al. “Novel Platform for MRI-Guided Convection-Enhanced Delivery of Therapeutics: Preclinical Validation in Nonhuman Primate Brain,”
[cited by applicant]
Russell, et al., “The Phosphodiesterase 10 Positron Emission Tomography Tracer, [18F]MNI-659, as a Novel Biomarker for Early Huntington Disease,”
[cited by applicant]
Salegio, et al., “Axonal Transport of Adeno-Associated Viral Vectors is Serotype-Dependent,”
[cited by applicant]
Samaranch, et al., “AAV9-Mediated Expression of a Non-Self Protein in Nonhuman Primate Cetral Nervous System Triggers Widespread Neuroinflammation Driven by Antigen-Presenting Cell Transduction,”
[cited by applicant]
San Sebastian, et al., “Adeno-Associated Virus Types 6 is Retrogradely Transported in the Non-Human Primate Brain,”
[cited by applicant]
San Sebastian, et al., “Safety and Tolerability of MRI-Guided Infusion of AAV2-HAADC Into the Mid-Brain of Nonhuman Primate,”
[cited by applicant]
Sander, et al., “CRISPR-CAS Systems for Editing, Regulation and Targeting,”
[cited by applicant]
Schornack, et al., “Gene-For-Gene-Mediated Recognition of Nuclear-Targeted AVRBS3-Like Bacterial Effector Proteins,”
[cited by applicant]
Shen, et al., “Terminal N-Linked Galactose is the Primary Receptor for Adeno-Associated Virus 9,”
[cited by applicant]
Sheng, et al., “Structure-Based Cleavage Mechanism of
[cited by applicant]
Sorek, et al., “CRISPR—A Widespread System That Provides Acquired Resistance Against Phages in Bacteria and Archaea,”
[cited by applicant]
Summerford, et al., “Membrane-Associated Heparan Sulfate Proteoglycan is a Receptor for Adeno-Associated Virus Type 2 Virions,”
[cited by applicant]
Swarts, et al., “DNA-Guided DNA Interference by a Prokaryotic Argonaute,”
[cited by applicant]
Tang, et al., “Identification of Novel Non-Coding RNAS as Potential Antisense Regulators in the Archaeon
[cited by applicant]
Tang, et al., “Identification Of 86 Candidates for Small Non-Messenger Rnas From the Archaeon
[cited by applicant]
Walker, “Huntington's Disease,”
[cited by applicant]
White, et al., “Huntingtin is Required for Neurogenesis and is Not Impaired by the Huntington's Disease CAG Expansion,”
[cited by applicant]
Wild, et al., “Quantifying Mutant Huntingtin in Huntington's Disease CSF,”
[cited by applicant]
Wu, et al., “Genome-Wide Binding of the Crispr Endonuclease CAS9 in Mammalian Cells,”
[cited by applicant]
Yu, et al., “An Engineered VEGF-Activating Zinc Finger Protein Transcription Factor Improves Blood Flow and Limb Salvage in Advanced-Age Mice,”
[cited by applicant]
Zuccato, et al., “Progressive Loss of Bdnf in a Mouse Model of Huntington's Disease and Rescue by BDNF Delivery,”
[cited by applicant]